Ratan Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Hold |
1,550
| – | – | 0.29% | 24 |
|
|
2025
Q1 | $771K | Sell |
1,550
-5,500
| -78% | -$2.74M | 0.25% | 27 |
|
|
2024
Q4 | $3.62M | Buy |
7,050
+1,550
| +28% | +$796K | 0.56% | 28 |
|
|
2024
Q3 | $3.4M | Sell |
5,500
-1,550
| -22% | -$959K | 0.92% | 23 |
|
|
2024
Q2 | $3.9M | Hold |
7,050
| – | – | 1.18% | 22 |
|
|
2024
Q1 | $4.1M | Sell |
7,050
-1,300
| -16% | -$756K | 2.18% | 14 |
|
|
2023
Q4 | $4.43M | Sell |
8,350
-1,700
| -17% | -$902K | 2.89% | 13 |
|
|
2023
Q3 | $5.09M | Buy |
10,050
+3,000
| +43% | +$1.52M | 3.85% | 9 |
|
|
2023
Q2 | $3.68M | Buy |
7,050
+5,500
| +355% | +$2.87M | 5.09% | 7 |
|
|
2023
Q1 | $893K | Hold |
1,550
| – | – | 2.37% | 11 |
|
|
2022
Q4 | $854K | Hold |
1,550
| – | – | 0.59% | 19 |
|
|
2022
Q3 | $786K | Sell |
1,550
-150
| -9% | -$76.1K | 1.86% | 13 |
|
|
2022
Q2 | $924K | Hold |
1,700
| – | – | 0.78% | 18 |
|
|
2022
Q1 | $1M | Hold |
1,700
| – | – | 0.7% | 23 |
|
|
2021
Q4 | $1.13M | Hold |
1,700
| – | – | 0.17% | 46 |
|
|
2021
Q3 | $971K | Sell |
1,700
-12,800
| -88% | -$7.31M | 0.13% | 72 |
|
|
2021
Q2 | $7.32M | Hold |
14,500
| – | – | 0.63% | 49 |
|
|
2021
Q1 | $6.62M | Buy |
14,500
+1,700
| +13% | +$776K | 0.73% | 46 |
|
|
2020
Q4 | $5.96M | Hold |
12,800
| – | – | 0.7% | 51 |
|
|
2020
Q3 | $5.65M | Hold |
12,800
| – | – | 0.83% | 44 |
|
|
2020
Q2 | $4.64M | Hold |
12,800
| – | – | 1.55% | 28 |
|
|
2020
Q1 | $3.63M | Hold |
12,800
| – | – | 1.69% | 20 |
|
|
2019
Q4 | $4.16M | Sell |
12,800
-1,400
| -10% | -$455K | 2.52% | 16 |
|
|
2019
Q3 | $4.14M | Hold |
14,200
| – | – | 2.19% | 21 |
|
|
2019
Q2 | $4.17M | Buy |
+14,200
| New | +$4.17M | 0.93% | 27 |
|